NCT06488950View on ClinicalTrials.gov

A Study on TIL for the Treatment of Advanced Solid Tumors

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2027

Conditions
Advanced Solid TumorTumor Infiltrating LymphocytesTreatment Side EffectsEffects of Immunotherapy
Interventions
BIOLOGICAL

GC203 TIL(gene-edited TIL) or autologous TILs

the candidates will be assigned to GC203 TIL(gene-edited TIL) group or autologous TILs group according the volume of TIL sample

Trial Locations (1)

Unknown

RECRUITING

Third Affiliated Hospital of Naval Medical University, Shanghai

All Listed Sponsors
collaborator

Third Affiliated Hospital of Naval Medical University

UNKNOWN

lead

Shanghai Juncell Therapeutics

INDUSTRY